Table 7.
Grouping/species | MAC | Mycobacterium kansasii | Other SGM | |||
---|---|---|---|---|---|---|
Antimicrobial agent | R (%, n/N) | MAC vs M. kansasii | R (%, n/N) | M. kansasii vs Other SGM | R (%, n/N) | MAC vs Other SGM |
p Value | P Value | P Value | ||||
Amikacin | 10.19 (11/108) | 0.12 | 0 (0/31) | 0.16 | 8 (4/50) | 0.88 |
Clarithromycin | 4.63 (5/108) | 0.35 | 0 (0/31) | 0.28 | 6 (3/50) | 1.00 |
Linezolid | 66.67 (72/108) | < 0.01a | 3.23 (1/31) | < 0.01a | 38 (19/50) | < 0.01a |
Moxifloxacin | 47.22 (51/108) | < 0.01a | 0 (0/31) | < 0.01a | 26 (13/50) | 0.01 |
SGM slow growing mycobacteria, MAC Mycobacterium avium‒intracellulare complex
aSignificant difference was observed in resistance rate (P < 0.01)